Brokerages Set Transcat, Inc. (NASDAQ:TRNS) PT at $127.25

Shares of Transcat, Inc. (NASDAQ:TRNS - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $127.25.

Several equities analysts recently weighed in on TRNS shares. Craig Hallum dropped their price objective on Transcat from $138.00 to $113.00 and set a "buy" rating for the company in a research note on Wednesday, October 30th. Northland Securities cut their price target on Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a research note on Wednesday, October 30th. Oppenheimer reissued an "outperform" rating and issued a $130.00 price objective (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. HC Wainwright restated a "buy" rating and set a $156.00 target price on shares of Transcat in a research report on Tuesday, October 29th. Finally, StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a research report on Tuesday, October 29th.

Transcat Stock Performance

Transcat stock traded up $1.38 during midday trading on Monday, reaching $103.44. The company's stock had a trading volume of 32,066 shares, compared to its average volume of 54,964. Transcat has a fifty-two week low of $94.29 and a fifty-two week high of $147.12. The firm has a market capitalization of $951.65 million, a PE ratio of 51.55 and a beta of 0.70. The stock's 50 day simple moving average is $112.31 and its 200 day simple moving average is $120.20.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The company had revenue of $67.83 million for the quarter, compared to analysts' expectations of $70.30 million. During the same period in the prior year, the firm posted $0.41 EPS. The firm's quarterly revenue was up 8.0% on a year-over-year basis. Equities analysts predict that Transcat will post 1.76 earnings per share for the current year.

Institutional Trading of Transcat

Hedge funds have recently bought and sold shares of the company. Conestoga Capital Advisors LLC grew its stake in shares of Transcat by 17.9% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company's stock valued at $109,561,000 after buying an additional 137,830 shares during the period. Champlain Investment Partners LLC boosted its holdings in Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company's stock valued at $49,455,000 after acquiring an additional 74,169 shares during the last quarter. Royce & Associates LP grew its position in Transcat by 8.2% during the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company's stock valued at $61,798,000 after acquiring an additional 38,774 shares during the period. Hood River Capital Management LLC increased its stake in Transcat by 21.6% during the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company's stock worth $23,558,000 after acquiring an additional 34,947 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company's stock valued at $9,577,000 after purchasing an additional 17,743 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.